Skip to main content
Mednow Inc. logo

Mednow Inc. — Investor Relations & Filings

Ticker · MNOW ISIN · CA58503L2021 TSXV Wholesale and retail trade
Open in API
Filings indexed 132 across all filing types
Latest filing 2021-06-29 Regulatory Filings
Country CA Canada
Listing TSXV MNOW

About Mednow Inc.

https://mednow.ca/

Mednow Inc. is a full-service virtual pharmacy utilizing a digital-first approach to deliver prescription medications, over-the-counter products, and comprehensive health services. The company provides fast, free delivery of medications and health products. Core offerings include unlimited virtual consultations with certified pharmacists, prescription management tools accessible via web or mobile application, and direct billing to insurance providers. A key service is PillSmart®, which organizes multiple daily medications into convenient, single-dose packages at no additional cost. Mednow focuses on improving patient access and adherence by offering expert advice and medication reviews seven days a week.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Mednow Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2021. The document is a certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certification and notes differences from non-venture issuer certifications. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself. The document length is short (3004 characters), and it is clearly a certification rather than the report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2021-06-29 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release dated June 29, 2021, reporting Mednow Inc.'s financial results for the third quarter ended April 30, 2021. It includes highlights such as IPO completion, trading start, strategic initiatives, and a summary of financial results with revenue, net loss, assets, and liabilities for the quarter and nine months ended April 30, 2021. The document also mentions that the detailed financial statements and Management Discussion & Analysis (MD&A) are available on SEDAR and the company's website, indicating this document is a summary announcement rather than the full report. The length is 8198 characters, which is relatively short for a full interim report but typical for an earnings release. The content focuses on key financial results and strategic updates, consistent with an Earnings Release (ER). It does not contain full financial statements or detailed analysis itself, which would be required for an Interim/Quarterly Report (IR). Therefore, the document is best classified as an Earnings Release (ER). Q3 2021
2021-06-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the filing of a pharmacy license application and the planned opening of a fulfillment center in Nova Scotia. It contains forward-looking statements about the company's expansion plans and operational timeline but does not include any financial statements, detailed financial performance data, or regulatory filings. It is an announcement of business development activities rather than a financial report or regulatory filing. Therefore, it fits best into the category of a general regulatory announcement or miscellaneous filing that does not fit into other specific categories, which corresponds to Regulatory Filings (RNS). The document length is moderate and contains no indication of being a full report or detailed financial disclosure.
2021-05-06 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the establishment of a proprietary telemedicine service by Mednow Inc. It details the formation of a new subsidiary, ownership structure, key personnel, and the expected launch timeline. There are no financial statements, regulatory filings, or detailed financial data presented. The content is primarily an operational business update and forward-looking statement rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement of a business development, which aligns best with a general Regulatory Filing (RNS) as a miscellaneous corporate announcement that does not fit other specific categories.
2021-05-04 English
News release - English.pdf
Transaction in Own Shares Classification · 95% confidence The document is a press release clarifying the conduct of a Normal Course Issuer Bid by Mednow Inc. It discusses the company's share repurchase activities through a brokerage on the TSX Venture Exchange. The content focuses on the share buyback process and does not contain financial statements, earnings data, or detailed financial analysis. The document length is 4508 characters, which is relatively short and primarily an announcement rather than a detailed report. Therefore, it fits the category of a Transaction in Own Shares (POS), which covers announcements of share repurchase activities.
2021-04-06 English
News release - English.pdf
Regulatory Filings
2021-03-29 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.